share_log

Demystifying Tenet Healthcare: Insights From 13 Analyst Reviews

Demystifying Tenet Healthcare: Insights From 13 Analyst Reviews

揭开泰尼特医疗的神秘面纱:13位分析师评审的见解
Benzinga ·  2024/11/22 23:00
Across the recent three months, 13 analysts have shared their insights on Tenet Healthcare (NYSE:THC), expressing a variety of opinions spanning from bullish to bearish.
在最近三个月中,13位分析师分享了他们对Tenet Healthcare(纽约证券交易所代码:THC)的见解,表达了从看涨到看跌的各种观点。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表简要概述了分析师最近的评级,提供了对过去30天情绪变化的见解,并与前几个月进行了比较以获得整体视角。
Analysts have recently evaluated Tenet Healthcare and provided 12-month price targets. The average target is $189.54, accompanied by a high estimate of $217.00 and a low estimate of $168.00. Marking an increase of 6.58%, the current average surpasses the previous average price target of $177.83.
分析师最近对Tenet Healthcare进行了评估,并提供了12个月的目标股价。平均目标为189.54美元,最高估计值为217.00美元,低估值为168.00美元。目前的平均价格上涨了6.58%,超过了之前的平均目标股价177.83美元。
Interpreting Analyst...
解读...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发